← Laws

Federal · H.R. 4739 · 116th Congress

Passed · U.S. House vote · Dec 9, 2019

Synthetic Opioid Exposure Prevention and Training Act

This bill directs the U.S. Customs and Border Protection (CBP) to implement a safety framework to protect its personnel from exposure to potential synthetic opioids. Among other things, the CBP must do the following: issue a policy that specifies protocols and procedures for the safe handling of potential synthetic opioids; require mandatory training on the potential risk of exposure to and safe handling procedures for synthetic opioids, as well as how to administer opioid receptor antagonists (e.g., naloxone) after exposure; and provide personal protective equipment and opioid receptor antagonists to officers, agents, other personnel, and canines at risk of exposure to synthetic opioids.

First two sentences of the Congressional Research Service's summary · Congress.gov ↗

What it does

This bill directs the U.S. Customs and Border Protection (CBP) to implement a safety framework to protect its personnel from exposure to potential synthetic opioids.

Where it stands

Passed the House on Dec 9, 2019. Waiting on the Senate.

How your reps voted

Find your representatives to see how yours voted.

First two sentences of the Congressional Research Service's summary · Congress.gov ↗. A plain-words version comes later. Official page ↗

Your reps

Find your representatives to see how yours voted.

Latest final vote: Passed · U.S. House · Dec 9, 2019

Official record ↗
Constitution

Not yet mapped. The parts of the Constitution this bill touches appear here once an analysis is written and checked.

Want an analysis of this bill? A full analysis maps every provision it touches.

All votes1 recorded

U.S. House · Dec 9, 2019 · Final passage

On Motion to Suspend the Rules and Pass · Passed

Official record ↗

By party

PartyYesNoPresentNot voting
Democratic1250010
Republican105007
Democrat13001
By state (44)
StateYesNoPresentNot voting
AL3001
AR3001
AZ5000
CA46005
CO3000
CT5000
DE1000
FL10003
GA7000
HI1000
ID2000
IL11001
IN3000
KS3000
KY5000
LA3000
MA6002
MD3000
ME2000
MI8000
MN5000
MO4000
MS3000
NC6000
NE2000
NH1000
NJ7000
NM1000
NV4000
NY10002
OH8000
OK3000
OR1000
PA13000
SC3001
SD1000
TN6000
TX17002
UT1000
VA5000
VT1000
WA6000
WI4000
WV1000

The breakdown counts the 261 members whose positions are loaded; the totals above are the official record's.

Party is as each member's record lists it. Counts are of recorded positions, nothing more.

Every member's vote

261 members, by last name.

Load more

From the official record of each vote. A member who left office keeps their recorded position; their page shows the years they served.

Money

Lobbying reports for this bill haven't been searched yet. They're searched for every bill in this Congress with a final-passage vote or committee action, newest first.

HistoryDec 9, 2019
  1. Dec 9, 2019U.S. House: On Motion to Suspend the Rules and Pass · Passed ↗

Recorded votes on this bill, passage without a recorded vote, and the final action, as their sources record them. Committee and other steps without a recorded vote aren't listed; the official page has every action.

Final action

Not checked yet. The President's action on a bill appears here after the data sync looks it up.

From Congress.gov's record of the bill's actions.

Full text
Full text on Congress.gov ↗ Official bill page ↗

Official summary (Congressional Research Service)

Synthetic Opioid Exposure Prevention and Training Act This bill directs the U.S. Customs and Border Protection (CBP) to implement a safety framework to protect its personnel from exposure to potential synthetic opioids. Among other things, the CBP must do the following: issue a policy that specifies protocols and procedures for the safe handling of potential synthetic opioids; require mandatory training on the potential risk of exposure to and safe handling procedures for synthetic opioids, as well as how to administer opioid receptor antagonists (e.g., naloxone) after exposure; and provide personal protective equipment and opioid receptor antagonists to officers, agents, other personnel, and canines at risk of exposure to synthetic opioids.

Source ↗